Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales57 99649 41448 51848 86450 60052 402
EBITDA19 36715 26014 31114 84415 78516 742
Operating profit (EBIT)14 61613 79012 98711 61412 69113 469
Pre-Tax Profit (EBT)11 9218 1347 8179 17810 42211 390
Net income10 21017 7836 7127 2958 3739 401
P/E ratio22,511,925,924,521,618,8
EPS ( $ )4,137,292,803,503,974,56
Dividend per Share ( $ )2,622,652,702,852,993,15
Yield2,82%3,06%3,72%3,32%3,49%3,67%
Reference price ( $ )92.8586.5972.6385.814585.814585.8145
Announcement Date01/27/2015
08:25am
01/27/2016
11:15am
01/25/2017
11:25am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt6 54916 48416 02517 70015 39412 576
Finance------
Operating income (EBITDA)19 36715 26014 31114 84415 78516 742
Leverage
(Debt/EBITDA)
0,34x1,08x1,12x1,19x0,98x0,75x
Capital Expenditure2 6242 3671 8622 0132 0512 110
Book Value Per Share (BVPS)27,7 $32,5 $31,5 $30,9 $31,5 $32,1 $
Cash Flow per Share5,63 $4,88 $4,78 $5,22 $5,67 $6,19 $
Announcement Date01/27/2015
08:25am
01/27/2016
11:15am
01/25/2017
11:25am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 226 404 M$ -
Entreprise Value (EV) 244 103 M$ 241 798 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 24,5x 21,6x
Capitalization / Revenue 4,63x 4,47x
EV / Revenue 5,00x 4,78x
EV / EBITDA 16,4x 15,3x
Yield (DPS / Price) 3,32% 3,49%
Price to book (Price / BVPS) 2,77x 2,72x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 23,8% 25,1%
operating Leverage (Delta EBIT / Delta Sales) - 2,61x
Net Margin (Net Profit / Revenue) 14,9% 16,5%
ROA (Net Profit / Asset) 7,11% 7,95%
ROE (Net Profit / Equities) 13,7% 15,1%
Rate of Dividend 81,5% 75,3%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,12% 4,05%
Cash Flow / Sales 25,0% 26,2%
Capital Intensity (Assets / Sales) 2,10x 2,08x
Financial Leverage (Net Debt / EBITDA) 1,19x 0,98x
EPS & Dividend